White Paper on CTSA Consortium Role in Facilitating Comparative Effectiveness Research
White Paper on CTSA Consortium Role in Facilitating Comparative Effectiveness Research
复制标题
DOI:
10.1111/j.1752-8062.2010.00177.x
复制
发表时间:
2010-02-01
影响因子:
3.9
通讯作者:
Whitlock, Evelyn P.
中科院分区:
文献类型:
--
作者:
Selker, Harry P.;Strom, Brian L.;Whitlock, Evelyn P.
In 2006, the National Institutes of Health (NIH) initiated the Clinical and Translational Science Awards (CTSAs) as part of the NIH Roadmap Initiative, in order to improve the conduct and impact of NIH's clinical and translational research portfolio. 1 The CTSA program is intended not only to transform the training programs and research infrastructure at individual academic institutions, but also to create a nation‐wide collaborative consortium to transform the biomedical research enterprise. In January 2009, the NIH CTSA National Consortium adopted Strategic Goals to maximize the CTSAs’ impact on the Nation's healthcare and health. Of these, the CTSA Strategic Goal 4 is to promote the translation of the results of clinical and translational research into practice and public policy. To advance this goal, a committee was constituted to focus on the organization and development of the CTSA Consortium's comparative eflEctiveness research (CER) capacity, an increasingly important component of research translation into practice and policy. This Committee's Workgroups took on a number of deliverables in service of this objective, including producing this White Paper on how the CTSA Consortium might best facilitate CER, for NIH's Institutes and Centers (ICs), other Federal agencies, outside stakeholders, and the healthcare system overall. This White Paper offers some specific suggestions for how the CTSA Consortium might support this emerging and crucial national effort to generate, synthesize, and disseminate CER in order to improve healthcare decision‐making and health outcomes.